Conmed (CNMD) Cash from Investing Activities (2010 - 2026)

Conmed's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• Quarterly Cash from Investing Activities rose 240.25% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.9 million (changed 0.42% YoY) and the FY2025 annual result came in at -$21.0 million, down 60.17% from the prior year.
• Cash from Investing Activities was $4.1 million for Q1 2026 at Conmed, up from -$7.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $4.1 million in Q1 2026 and bottomed at -$148.3 million in Q2 2022.
• A 5-year average of -$17.6 million and a median of -$4.9 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 4852.1% — and 2026, when it surged 240.25%.
• Conmed's Cash from Investing Activities stood at -$6.3 million in 2022, then climbed by 23.16% to -$4.9 million in 2023, then gained by 16.79% to -$4.0 million in 2024, then plunged by 76.01% to -$7.1 million in 2025, then jumped by 157.77% to $4.1 million in 2026.
• Business Quant data shows CNMD's Cash from Investing Activities at $4.1 million in Q1 2026, -$7.1 million in Q4 2025, and -$5.2 million in Q3 2025.